Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Additive effect of vitamin K supplementation and bisphosphonate on fracture risk in post-menopausal osteoporosis
2010-022587-12Phase 2Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of phytomenadione and menatetrenone in osteoporosis, sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoints: Change in bone mineral density at lumbar spine, Change in bone mineral density at total hip and 1 more. Started Nov 2014; status: completed.
02
Drugs
phytomenadionemenatetrenone
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2010-022587-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022587-12.